We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current PRQR market cap is 154.53M. The company's latest EPS is EUR -0.3456 and P/E is -5.44.
| Quarter End | Mar 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 141k | 1.34M | 1.03M | 1.65M | 697k |
| Operating Income | -12.21M | -16.95M | -19.68M | -12.02M | -9.39M |
| Net Income | -12.61M | -14.44M | -24.4M | -13.98M | -8.93M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 1.93M | 9.45M | 2.4M | 4.8M | 6.59M |
| Operating Income | -57.02M | -42.69M | -56.89M | -64.72M | -34.7M |
| Net Income | -56.48M | -46.57M | -61.62M | -65.11M | -28.12M |
| Quarter End | Mar 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 91.61M | 190.23M | 121.73M | 171.32M | 158.01M |
| Total Liabilities | 42.43M | 90.02M | 57.19M | 106.21M | 99.31M |
| Total Equity | 49.18M | 100.22M | 64.54M | 65.11M | 58.7M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 117.54M | 98.73M | 209.58M | 171.32M | 137.88M |
| Total Liabilities | 23.7M | 42.18M | 96.35M | 106.21M | 96.49M |
| Total Equity | 93.83M | 56.55M | 113.23M | 65.11M | 41.39M |
| Quarter End | Mar 2021 | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -11.76M | -20.47M | -15.36M | -68.51M | 44.73M |
| Investing | -32k | -244k | -246k | -702k | -89k |
| Financing | 2.99M | -543k | -43.75M | -30.89M | -259k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -43.97M | -47.06M | -26.01M | -68.51M | 21.55M |
| Investing | -580k | -924k | -425k | -702k | 4.28M |
| Financing | 50.2M | 14.5M | 136.83M | -30.89M | -2.28M |
| Market Cap | 154.53M |
| Price to Earnings Ratio | -5.44 |
| Price to Sales Ratio | 23.18 |
| Price to Cash Ratio | 1.29 |
| Price to Book Ratio | 3.7 |
| Dividend Yield | - |
| Shares Outstanding | 81.35M |
| Average Volume (1 week) | 181.02k |
| Average Volume (1 Month) | 156.08k |
| 52 Week Change | -18.13% |
| 52 Week High | 3.29 |
| 52 Week Low | 1.11 |
| Spread (Intraday) | 0.28 (13.46%) |
| Company Name | ProQR Therapeutics NV |
| Address |
zernikedreef 9 leiden, south holland 2333 CK |
| Website | https://www.proqr.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
